Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 42: 1034-1041, 1996;
This Article
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Piironen, T.
Right arrow Articles by Pettersson, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Piironen, T.
Right arrow Articles by Pettersson, K.

Clinical Chemistry, Vol 42, 1034-1041, Copyright © 1996 by American Association for Clinical Chemistry

Immunofluorometric assay for sensitive and specific measurement of human prostatic glandular kallikrein (hK2) in serum

T Piironen, J Lovgren, M Karp, R Eerola, A Lundwall, B Dowell, T Lovgren, H Lilja and K Pettersson
Department of Biotechnology, University of Turku, Finland. timo.piironen@utu.fi

Prostate-specific antigen (PSA) and human prostatic glandular kallikrein (hK2) have 79% identity with the primary structure. When we used recombinant hK2 protein, only 7 of 23 monoclonal anti-PSA IgGs (monoclonal antibodies, MAbs) cross-reacted with hK2, which enabled us to design a novel immunofluorometric MAb-MAb assay for the specific detection of hK2. In the first incubation, an excess of MAb 2H11, which does not cross-react with hK2, is added to prevent both free and complexed PSA from reacting in subsequent immunoreactions. In the second incubation, biotinylated MAb H50, which cross-reacts with hK2 by an epitope overlapping with MAb 2H11, served to bind only hK2 to the microtitration wells coated with streptavidin. In the third step, Eu- labeled MAb H117, which cross-reacts with hK2, detected the immobilized hK2. The hK2 assay was calibrated with recombinant hK2. The detection limit of the assay was 0.1 microgram/L, and the cross-reactivity with recombinant PSA was < or = 0.7%. The concentration of hK2 was measured in serum samples from 334 males with total PSA concentrations ranging from 1 to 3400 microgram/L. Most of the samples (57%) had hK2 concentrations below the detection limit. The proportions of hK2 relative to total PSA were 0-2% in 79%, 2-5% in 14%, 5-10% in 4%, and >10% in 3% of the samples. Gel filtration of 10 serum samples with increased hK2 concentrations showed a single peak of hK2 immunoreactivity with an apparent molecular size of approximately 30 kDa, corresponding to that of recombinant hK2 and free PSA.


The following articles in journals at HighWire Press have cited this article:


Home page
 Clin. Chem.Home page
V. Vaisanen, S. Eriksson, K. K. Ivaska, H. Lilja, M. Nurmi, and K. Pettersson
Development of Sensitive Immunoassays for Free and Total Human Glandular Kallikrein 2
Clin. Chem., September 1, 2004; 50(9): 1607 - 1617.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
A. Haese, V. Vaisanen, J. A. Finlay, K. Pettersson, H. G. Rittenhouse, A. W. Partin, D. J. Bruzek, L. J. Sokoll, H. Lilja, and D. W. Chan
Standardization of Two Immunoassays for Human Glandular Kallikrein 2
Clin. Chem., April 1, 2003; 49(4): 601 - 610.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
B. G. Blijenberg, M. F. Wildhagen, C. H. Bangma, J. A. Finlay, V. Vaisanen, and F. H. Schroder
Comparison of Two Assays for Human Kallikrein 2
Clin. Chem., February 1, 2003; 49(2): 243 - 247.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
J. A. Finlay, J. R. Day, C. L. Evans, R. Carlson, K. Kuus-Reichel, L. S. Millar, S. D. Mikolajczyk, M. Goodmanson, G. G. Klee, and H. G. Rittenhouse
Development of a Dual Monoclonal Antibody Immunoassay for Total Human Kallikrein 2
Clin. Chem., July 1, 2001; 47(7): 1218 - 1224.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
C. Stephan, K. Jung, M. Lein, P. Sinha, D. Schnorr, and S. A. Loening
Molecular Forms of Prostate-specific Antigen and Human Kallikrein 2 as Promising Tools for Early Diagnosis of Prostate Cancer
Cancer Epidemiol. Biomarkers Prev., November 1, 2000; 9(11): 1133 - 1147.
[Abstract] [Full Text]

Home page
 Clin. Chem.Home page
C. Becker, T. Piironen, J. Kiviniemi, H. Lilja, and K. Pettersson
Sensitive and Specific Immunodetection of Human Glandular Kallikrein 2 in Serum
Clin. Chem., February 1, 2000; 46(2): 198 - 206.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
M. H. Black, A. Magklara, C. V. Obiezu, D. N. Melegos, and E. P. Diamandis
Development of an Ultrasensitive Immunoassay for Human Glandular Kallikrein with No Cross-Reactivity from Prostate-specific Antigen
Clin. Chem., June 1, 1999; 45(6): 790 - 799.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
G. G. Klee, M. K. Goodmanson, S. J. Jacobsen, C. Y.F. Young, J. A. Finlay, H. G. Rittenhouse, R. L. Wolfert, and D. J. Tindall
Highly Sensitive Automated Chemiluminometric Assay for Measuring Free Human Glandular Kallikrein-2
Clin. Chem., June 1, 1999; 45(6): 800 - 806.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
M. S. Saedi, T. M. Hill, K. Kuus-Reichel, A. Kumar, J. Payne, S. D. Mikolajczyk, R. L. Wolfert, and H. G. Rittenhouse
The precursor form of the human kallikrein 2, a kallikrein homologous to prostate-specific antigen, is present in human sera and is increased in prostate cancer and benign prostatic hyperplasia
Clin. Chem., October 1, 1998; 44(10): 2115 - 2119.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 by the American Association for Clinical Chemistry.